Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae

Future Microbiology

Volumn 7, Issue 3, 2012, Pages 395-410

  Hakenbeck, Regine ^a   Brückner, Reinhold ^a   Denapaite, Dalia ^a   Maurer, Patrick ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

cefotaxime; horizontal gene transfer; muropeptide; penicillin resistance; penicillin binding protein; Streptococcus pneumoniae; transpeptidase

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1A; PENICILLIN BINDING PROTEIN 1B; PENICILLIN BINDING PROTEIN 2A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; PENICILLIN BINDING PROTEIN 3; PENICILLIN G; PEPTIDOGLYCAN; PIPERACILLIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BINDING AFFINITY; CONCENTRATION RESPONSE; DRUG MECHANISM; GENE STRUCTURE; GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PENICILLIN RESISTANCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; HUMANS; PENICILLIN-BINDING PROTEINS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 84858024596     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.2     Document Type: Review

References (144)

1. Gunnison JB, Fraher MA, Pelcher EA, Jawetz E. Penicillin-resistant variants of pneumococci. Appl. Microbiol. 16, 311-314 (1968).
2. Kislak JW, Razavi LM, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am. J. Med. Sci. 250, 261-268 (1965).
3. Hansman D. Antibiotic sensitivity pattern of pneumococci relatively insensitive to penicillin and cephalosporin antibiotics. Med. J. Aust. 2, 740-742 (1975).
4. Jacobs MR, Koornhof HJ, Robins-Browne RM et al. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299, 735-740 (1978).
5. Henriques-Normark B. Molecular epidemiology and mechanisms for antibiotic resistance in Streptococcus pneumoniae. In: Molecular Biology of Streptococci. Hakenbeck R, Chhatwal GS (Eds). Horizon Press, Wymondham, Norfolk, UK, 269-290. (2007).
6. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46, 767-773 (2000).
7. McDougal LK, Rasheed JK, Biddle JW, Tenover FC. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob. Agents Chemother. 39, 2282-2288 (1995).
8. Smith AM, Botha RF, Koornhof HJ, Klugman KP. Emergence of a pneumococcal clone with cephalosporin resistance and penicillin susceptibility. Antimicrob. Agents Chemother. 45, 2648-2650 (2001).
9. CDC. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae - United States, 2006-2007. Morb. Mort. Weekly Report 57, 1353-1355 (2008).
10. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40, 891-894 (1996).
11. Potgieter E, Carmichael M, Koornhof HJ, Chalkley LJ. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 11, 543-546 (1992).
12. Carratalà J, Alcaide F, Fernández-Sevilla A, Corbella X, Liñares J, Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin. Infect. Dis. 20, 1169-1173 (1995).
13. Dowson CG, Hutchison A, Spratt BG. Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2b of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol. Microbiol. 3, 95-102 (1989).
14. Laible G, Spratt BG, Hakenbeck R. Inter-species recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 5, 1993-2002 (1991).
15. Maiden MCJ, Bygraves JA, Feil E et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl Acad. Sci. USA 95, 3140-3145 (1998).
16. McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiological Network (PMEN). J. Clin. Microbiol. 39, 2565-2571 (2001).
17. Croucher NJ, Harris SR, Fraser C et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
18. Gasc AM, Geslin P, Sicard AM. Relatedness of penicillin-resistant Streptococcus pneumoniae serogroup 9 strains from France and Spain. Microbiology 141, 623-627 (1995).
19. Reichmann P, Varon E, Günther E et al. Penicillin-resistant Streptococcus pneumoniae in Germany: genetic relationship to clones from other European countries. J. Med. Microbiol. 43, 377-385 (1995).
20. Karnezis TT, Smith A, Whittier S, Haddad J, Saiman L. Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine. PLoS ONE 4, E5965 (2009).
21. Morand B, Muhlemann K. Heteroresistance to penicillin in Streptococcus pneumoniae. Proc. Natl Acad. Sci. USA 104, 14098-14103 (2007).
22. Goffin C, Ghuysen J-M. Biochemistry and comparative genomics of SXXK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol. Mol. Biol. Rev. 66, 706-738 (2002).
23. Sauvage E, Kerff F, Terrak M, Ayala J, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234-258 (2008).
24. Suzuki H, van Heijenoort Y, Tamura T, Mizoguchi J, Hirota Y, Van Heijenoort J. In vitro peptidoglycan polymerization catalysed by penicillin-binding protein 1b of Escherichia coli K 12. FEBS Lett. 110, 245-249 (1980).
25. Stanhope MJ, Lefebure T, Walsh SL et al. Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development. Infect. Genet. Evol. 8, 331-339 (2008).
26. Frère J-M, Joris B. Penicillin-sensitive enzymes in peptidoglycan biosynthesis. Crit. Rev. Microbiol. 11, 299-396 (1985).
27. Adam M, Damblon C, Jamin M et al. Acyltransferase activities of the high-molecular-mass essential penicillin-binding proteins. Biochem. J. 279, 601-604 (1991).
28. Jamin M, Hakenbeck R, Frère J-M. Penicillin binding protein 2x as a major contributor to intrinsic b-lactam resistance of Streptococcus pneumoniae. FEBS Lett. 331, 101-104 (1992).
29. Briese T, Ellerbrok H, Schier H-M, Hakenbeck R. Reactivity of anti-b-lactam antibodies with b-lactam-penicillin-binding protein complexes. In: Antibiotic Inhibition of Bacterial Cell Surface Assembly and Function. Actor P, Daneo-Moore L, Higgins ML, Salton MRJ, Shockman GD (Eds). American Society for Microbiology, WA, USA, 404-409 (1988).
30. Hakenbeck R, Briese T, Ellerbrok H. Antibodies against the benzylpenicilloyl moiety as a probe for penicillin-binding proteins. Eur. J. Biochem. 157, 101-106 (1986).
31. Hakenbeck R, Briese T, Chalkley L et al. Antigenic variation of penicillin-binding proteins from penicillin resistant clinical strains of Streptococcus pneumoniae. J. Infect. Dis. 164, 313-319 (1991).
32. Rutschmann J, Maurer P, Hakenbeck R. Detection of penicillin-binding proteins. In: Molecular Biology of Streptococci. Hakenbeck R, Chhatwal GS (Eds). Horizon Bioscience, Wymondham, Norfolk, UK, 537-542. (2007).
33. Denapaite D, Chi F, Maurer P, Nolte O, Hakenbeck R. Mechanism of penicillin resistance in Streptococcus pneumoniae: targets, gene transfer, and mutations. In: Molecular Biology of Streptococci. Hakenbeck R, Chhatwal GS (Eds). Horizon Bioscience, Wymondham, Norfolk UK, 290-303 (2007).
34. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and β-lactam resistance. FEMS Microbiol. Rev. 32, 361-385 (2008).
35. Kell CM, Sharma UK, Dowson CG, Town C, Balganesh TS, Spratt BG. Deletion analysis of the essentiality of penicillin-binding proteins 1a, 2b and 2x of Streptococcus pneumoniae. FEMS Microbiol. Lett. 106, 171-175 (1993).
36. Paik J, Kern I, Lurz R, Hakenbeck R. Mutational analysis of the Streptococcus pneumoniae bimodular class A penicillin-binding proteins. J. Bacteriol. 181, 3852-3856 (1999).
37. Hoskins J, Matsushima P, Mullen DL et al. Gene disruption studies of penicillin-binding proteins 1a, 1b and 2a in Streptococcus pneumoniae. J. Bacteriol. 181, 6552-6555 (1999).
38. Di Guilmi AM, Dessen A, Dideberg O, Vernet T. The glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae catalyzes the polymerization of murein glycan chains. J. Bacteriol. 185, 4418-4423 (2003).
39. Di Guilmi AM, Dessen A, Dideberg O, Vernet T. Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae. J. Bacteriol. 185, 1650-1658 (2003).
40. Schuster C, Dobrinski B, Hakenbeck R. Unusual septum formation in Streptococcus pneumoniae mutants with an alteration in the D,D-carboxypeptidase penicillin-binding protein 3. J. Bacteriol. 172, 6499-6505 (1990).
41. Severin A, Schuster C, Hakenbeck R, Tomasz A. Altered murein composition in a DD-carboxypeptidase mutant of Streptococcus pneumoniae. J. Bacteriol. 174, 5125-5155 (1992).
42. Morlot C, Zapun A, Dideberg O, Vernet T. Growth and division of Streptococcus pneumoniae: localization of the high molecular weight penicillin-binding proteins during the cell cycle. Mol. Microbiol. 50, 845-855 (2003). Links the localization of high molecular mass penicillin-binding proteins (PBPs) to their putative biological function during cell wall biosynthesis.
43. Zapun A, Vernet T, Pinho MG. The different shapes of cocci. FEMS Microbiol. Rev. 32, 345-360 (2008).
44. Hakenbeck R, Ellerbrok H, Martin C et al. Penicillin-binding protein 1a and 3 in Streptococcus pneumoniae: what are essential PBP's. In: Bacterial Growth and Lysis Metabolism and Structure of the Bacterial Sacculus. De Pedro MA, Höltje J-V, Löffelhardt W (Eds). Plenum Press, New York, NY, USA 335-340. (1993).
45. Morlot C, Noirclerc-Savoye M, Zapun A, Dideberg O, Vernet T. The D,D-carboxypeptidase PBP3 organizes the division process of Streptococcus pneumoniae. Mol. Microbiol. 51, 1641-1648 (2004).
46. Mattei PJ, Neves D, Dessen A. Bridging cell wall biosynthesis and bacterial morphogenesis. Curr. Opin. Struct. Biol. 20, 749-755 (2010).
47. Hakenbeck R, Tornette S, Adkinson NF. Interaction of non-lytic b-lactams with penicillin-binding proteins in Streptococcus pneumoniae. J. Gen. Microbiol. 133, 755-760 (1987).
48. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob. Agents Chemother. 40, 829-834 (1996).
49. Laible G, Hakenbeck R. Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae. J. Bacteriol. 173, 6986-6990 (1991).
50. Sifaoui F, Kitzis M-D, Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrob. Agents Chemother. 40, 152-156 (1996).
51. Negri MC, Morosini MI, Baquero MR, del Campo R, Blázquez J, Baquero F. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 46, 528-530 (2002).
52. Liu HH, Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J. Infect. Dis. 152, 365-372 (1985).
53. Reichmann P, König A, Liñares J et al. A global gene pool for high-level cephalosporin resistance in commensal Streptococcus spp. and Streptococcus pneumoniae. J. Infect. Dis. 176, 1001-1012 (1997).
54. Muñóz R, Dowson CG, Daniels M et al. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6, 2461-2465 (1992).
55. Rieux V, Carbon C, Zoulay-Dupuis E. Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae. J. Infect. Dis. 184, 66-72 (2001).
56. Albarracin Orio AG, Pinas GE, Cortes PR, Cian MB, Echenique J. Compensatory evolution of pbp mutations restores the fitness cost imposed by beta-lactam resistance in Streptococcus pneumoniae. PLoS Pathog. 7, E1002000 (2011).
57. 338. Antimicrob. Agents Chemother. 53, 1107-1115 (2009). Physiological consequences of PBP2x mutations are described.
58. Job V, Carapito R, Vernet T, Dessen A, Zapun A. Common alterations in PBP1a from resistant Streptococcus pneumoniae decrease its reactivity toward beta-lactams: structural insights. J. Biol. Chem. 283, 4886-4894 (2008).
59. Dowson CG, Hutchison A, Brannigan JA et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc. Natl Acad. Sci. USA 86, 8842-8846 (1989).
60. Martin C, Sibold C, Hakenbeck R. Relatedness of penicillin-binding protein 1a genes from different clones of penicillin-resistant Streptococcus pneumoniae isolated in South Africa and Spain. EMBO J. 11, 3831-3836 (1992).
61. Sibold C, Henrichsen J, König A, Martin C, Chalkley L, Hakenbeck R. Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis. Mol. Microbiol. 12, 1013-1023 (1994). The contribution of Streptococcus mitis to mosaic gene structure is outlined.
62. Enright MC, Spratt BG. Extensive variation in the ddl gene of penicillin-resistant Streptococcus pneumoniae results from a hitchhiking effect driven by the penicillin-binding protein 2b gene. Mol. Biol. Evol. 16, 1687-1695 (2004).
63. Coffey TJ, Enright MC, Daniels M et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol. Microbiol. 27, 73-83 (1998).
64. Trzcinski K, Thompson CM, Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J. Bacteriol. 186, 3227-3452 (2006).
65. r penicillin-binding protein variants during transfer of high-level b-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J. Bacteriol. 180, 1831-1840 (1998).
66. Chi F, Nolte O, Bergmann C, Ip M, Hakenbeck R. Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in S. pneumoniae, S. mitis and S. oralis. Int. J. Med. Microbiol. 297, 503-512 (2007). Outlines the participation of Streptococcus oralis, S. mitis and Streptococcus pneumoniae in a global gene pool.
67. 6B-20. J. Bacteriol. 52, 1021-1027 (2008).
68. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2b in S. pneumoniae. Mol. Microbiol. 9, 635-643 (1993). The contribution of S. mitis to mosaic gene structure is outlined.
69. Pares S, Mouz N, Pétillot Y, Hakenbeck R, Dideberg O. X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme. Nat. Struct. Biol. 3, 284-289 (1996).
70. Krauss J, van der Linden M, Grebe T, Hakenbeck R. Penicillin-binding proteins 2x and 2b as primary PBP-targets in Streptococcus pneumoniae. Microb. Drug Resist. 2, 183-186 (1996).
71. Maurer P, Koch B, Zerfass I et al. Penicillin-Binding Protein 2x of Streptococcus pneumoniae: Three new mutational pathways for remodelling an essential enzyme into a resistance determinant. J. Mol. Biol. 376, 1403-1416 (2008). Tackles the flexibility of mutational pathways and putative structural consequences.
72. Laible G, Hakenbeck R. Penicillin-binding proteins in β-lactam-resistant laboratory mutants of Streptococcus pneumoniae. Mol. Microbiol. 1, 355-363 (1987).
73. Coffey TJ, Daniels M, McDougal LK, Dowson CG, Tenover FC, Spratt BG. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 39, 1306-1313 (1995).
74. Sanbongi Y, Ida T, Ishikawa M et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob. Agents Chemother. 48, 2244-2250 (2004).
75. Asahi Y, Takeuchi Y, Ubukata K. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding rotein 2x in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 43, 1252-1255 (1999).
76. Nagai K, Davies TA, Jacobs MR, Appelbaum PC. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob. Agents Chemother. 46, 1273-1280 (2002).
77. Mouz N, Di Guilmi AM, Gordon E, Hakenbeck R, Dideberg O, Vernet T. Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for b-lactam antibiotics. J. Biol. Chem. 274, 19175-19180 (1999).
78. Gordon E, Mouz N, Duee E, Dideberg O. The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. J. Mol. Biol. 299, 477-485 (2000).
79. Mouz N, Gordon E, Di Guilmi D-M et al. Identification of a structural determinant for resistance to β-lactam antibiotics in Gram-positive bacteria. Proc. Natl Acad. Sci. USA 95, 13403-13406 (1998).
80. Hakenbeck R, Kaminski K, König A et al. Penicillin-binding proteins in β-lactam-resistant Streptococcus pneumoniae. Microb. Drug Resist. 5, 91-99 (1999).
81. Dessen A, Mouz N, Gordon E, Hopkins J, Dideberg O. Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations. J. Biol. Chem. 276, 45105-45112 (2001). Tackles the flexibility of mutational pathways and putative structural consequences.
82. Chesnel L, Pernot L, Lemaire D et al. The structural modifications induced by the M339F substitution in PBP2x from Streptococcus pneumoniae further decreases the susceptibility to beta-lactams of resistant strains. J. Biol. Chem. 278, 44448-44456 (2003).
83. Pernot L, Chesnel L, Le Gouellec A et al. A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics. J. Biol. Chem. 279, 16463-16470 (2004).
84. Carapito R, Chesnel L, Vernet T, Zapun A. Pneumococcal beta-lactam resistance due to a conformational change in penicillin-binding protein 2x. J. Biol. Chem. 281, 1771-1777 (2006).
85. Smith AM, Klugman KP. Amino acid mutations essential to production of an altered PBP 2x conferring high-level beta-lactam resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 49, 4622-4627 (2005).
86. Lu W-P, Kincaid E, Sun Y, Bauer MD. Kinetics of beta-lactam interactions with penicillin-susceptible and -resistant penicillin-binding protein 2x proteins from Streptococcus pneumoniae. Involvement of acylation and deacylation in beta-lactam resistance. J. Biol. Chem. 276, 31494-31501 (2001).
87. Di Guilmi AM, Mouz N, Petillot Y, Forest E, Dideberg O, Vernet T. Deacylation kinetics analysis of Streptococcus pneumoniae penicillin-binding protein 2x mutants resistant to beta-lactam antibiotics using electrospray ionization- mass spectrometry. Anal. Biochem. 10, 240-246 (2000).
88. Jamin M, Damblon C, Millier S, Hakenbeck R, Frère J-M. Penicillin-binding protein 2x of Streptococcus pneumoniae: enzymic activities and interactions with β-lactams. Biochem. J. 292, 735-741 (1993).
89. Hakenbeck R, Martin C, Dowson C, Grebe T. Penicillin-binding protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory mutants. J. Bacteriol. 176, 5574-5577 (1994).
90. Smith AM, Klugman KP. Alterations in penicillin-binding protein 2b from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39, 859-867 (1995).
91. Ferroni A, Berche P. Alterations to penicillin-binding proteins 1a, 2b and 2x amongst penicillin-resistant clinical isolates of Streptococcus pneumoniae serotype 23F from the nasopharyngeal flora of children. J. Med. Microbiol. 50, 828-832 (2001).
92. Pagliero E, Chesnel L, Hopkins J et al. Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in beta-lactam resistance. Antimicrob. Agents Chemother. 48, 1848-1855 (2004).
93. Song JH, Yang JW, Jin JH et al. Molecular characterization of multidrug-resistant Streptococcus pneumoniae isolates in Korea. The Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. J. Clin. Microbiol. 38, 1641-1644 (2000).
94. Kell CM, Jordens JZ, Daniels M et al. Molecular epidemiology of penicillin-resistant pneumococci isolated in Nairobi, Kenya. Infect. Immun. 61, 4382-4391 (1993).
95. du Plessis M, Bingen E, Klugman KP. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob. Agents Chemother. 46, 2349-2357 (2002).
96. Kosowska K, Jacobs MR, Bajaksouzian S, Koeth L, Appelbaum PC. Alterations of penicillin-binding proteins 1a, 2x, and 2b in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob. Agents Chemother. 48, 4020-4022 (2004).
97. Cafini F, del Campo R, Alou L et al. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain. J. Antimicrob. Chemother. 57, 224-229 (2006).
98. Yamane A, Nakano H, Asahi Y, Ubukata K, Konno M. Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2b gene of penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40, 1257-1259 (1996).
99. Contreras-Martel C, Dahout-Gonzalez C, Martins Ados S, Kotnik M, Dessen A. PBP active site flexibility as the key mechanism for beta-lactam resistance in pneumococci. J. Mol. Biol. 387, 899-909 (2009). Outlines the consequences of mutations for the interaction with inhibitors - old and new.
100. Smith AM, Klugman KP. Alterations in PBP1a essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42, 1329-1333 (1998).
101. Smith AM, Klugman KP. Site-specific mutagenesis analysis of PBP 1a from a penicillin-cephalosporin-resistant pneumococcal isolate. Antimicrob. Agents Chemother. 48, 387-389 (2003).
102. Job V, Di Guilmi AM, Martin L, Vernet T, Dideberg O, Dessen A. Structural studies of the transpeptidase domain of PBP1a from Streptococcus pneumoniae. Acta Crystallogr. D Biol. Crystallogr. 59, 1067-1069 (2003).
103. Contreras-Martel C, Job V, Di Guilmi AM, Vernet T, Dideberg O, Dessen A. Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae. J. Mol. Biol. 355, 684-696 (2006).
104. du Plessis M, Smith AM, Klugman KP. Analysis of penicillin-binding protein lb and 2a genes from Streptococcus pneumoniae. Microb. Drug Resist. 6, 127-131 (2000).
105. Carapito R, Gallet B, Zapun A, Vernet T. Automated high-throughput process for site-directed mutagenesis, production, purification, and kinetic characterization of enzymes. Anal. Biochem. 355, 110-116 (2006).
106. Smith AM, Feldman C, Massidda O, McCarthy K, Ndiweni D, Klugman KP. Altered PBP 2a and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 49, 2002-2007 (2005).
107. Zhao G, Meier TI, Hoskins J, McAllister KA. Identification and characterization of the penicillin-binding protein 2a of Streptococcus pneumoniae and its possible role in resistance to beta-lactam antibiotics. Antimicrob. Agents Chemother. 44, 1745-1748 (2000).
108. Krauss J, Hakenbeck R. A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604. Antimicrob. Agents Chemother. 41, 936-942 (1997).
109. Selakovitch-Chenu L, Seroude L, Sicard AM. The role of penicillin-binding protein 3 (PBP 3) in cefotaxime resistance in Streptococcus pneumoniae. Mol. Gen. Genet. 239, 77-80 (1993).
110. Denapaite D, Brückner R, Nuhn M et al. The genome of Streptococcus mitis B6 - what is a commensal? PLoS ONE 5, E9426 (2010).
111. Garcia-Bustos JF, Chait BT, Tomasz A. Structure of the peptide network of pneumococcal peptidoglycan. J. Biol. Chem. 262, 15400-15405 (1987).
112. Lloyd AJ, Gilbey AM, Blewett AM et al. Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan. J. Biol. Chem. 283, 6402-6417 (2008). In vitro studies represent the basis for understanding the activity of MurM variants on molecular terms.
113. De Pascale G, Lloyd AJ, Schouten JA et al. Kinetic characterization of lipid II-Ala:alanyl-tRNA ligase (MurN) from Streptococcus pneumoniae using semisynthetic aminoacyl-lipid II substrates. J. Biol. Chem. 283, 34571-34579 (2008).
114. Garcia-Bustos J, Tomasz A. A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl Acad. Sci. USA 87, 5415-5419 (1990).
115. Smith AM, Klugman KP. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45, 2393-2396 (2001).
116. Filipe SR, Severina E, Tomasz A. The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae. Proc. Natl Acad. Sci. USA 99, 1550-1555 (2002). Characterizes the physiological consequences of murM mutants in the context of resistant clinical isolates.
117. Weber B, Ehlert K, Diehl A, Reichmann P, Labischinski H, Hakenbeck R. The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance. FEMS Microbiol. Lett. 188, 81-85 (2000). Characterizes the physiological consequences of murM mutants in the context of resistant clinical isolates.
118. Filipe SR, Tomasz A. Inhibition of the expression of penicillin- resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. Proc. Natl Acad. Sci. USA 97, 4891-4896 (2000).
119. Severin A, Figueiredo AMS, Tomasz A. Separation of abnormal cell wall composition from penicillin resistance through genetic transformation of Streptococcus pneumoniae. J. Bacteriol. 178, 1788-1792 (1996).
120. Chesnel L, Carapito R, Croizé J, Dideberg O, Vernet T, Zapun A. Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance. Antimicrob. Agents Chemother. 49, 2895-2902 (2005).
121. Tait-Kamradt AG, Cronan M, Dougherty TJ. Comparative genome analysis of high-level penicillin resistance in Streptococcus pneumoniae. Microb. Drug Resist. 15, 69-75 (2009).
122. Crisostomo MI, Vollmer W, Kharat AS et al. Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae. Mol. Microbiol. 61, 1497-1509 (2006).
123. Soualhine H, Brochu V, Menard F et al. A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol. Microbiol. 58, 1430-1440 (2005).
124. Hakenbeck R, Grebe T, Zähner D, Stock JB. b-Lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non penicillin-binding proteins. Mol. Microbiol. 33, 673-678 (1999).
125. Grebe T, Paik J, Hakenbeck R. A novel resistance mechanism for β-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferases. J. Bacteriol. 179, 3342-3349 (1997).
126. Edman M, Berg S, Storm P et al. Structural features of glycosyltransferases synthesizing major bilayer and nonbilayer-prone membrane lipids in Acholeplasma laidlawii and Streptococcus pneumoniae. J. Biol. Chem. 278, 8420-8428 (2003).
127. Seo HS, Cartee RT, Pritchard DG, Nahm MH. A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model. J. Bacteriol. 190, 2379-2387 (2008).
128. Guenzi E, Gasc AM, Sicard MA, Hakenbeck R. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol. Microbiol. 12, 505-515 (1994).
129. Moscoso M, Domenech M, García E. Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide. Mol. Microbiol. 77, 1052-1064 (2010).
130. Müller M, Marx P, Hakenbeck R, Brückner R. Effect of new alleles of the histidine kinase gene ciaH on the activity of the response regulator CiaR in Streptococcus pneumoniae R6. Microbiology 157, 3104-3112 (2011).
131. Mascher T, Heintz M, Zähner D, Merai M, Hakenbeck R. The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and mutations in pbp2x involved in beta-lactam resistance. J. Bacteriol. 188, 1959-1968 (2006). Physiological consequences of PBP2x mutations are described.
132. Halfmann A, Schnorpfeil A, Müller M et al. Activity of the two-component regulatory system CiaRH in Streptococcus pneumoniae R6. J. Mol. Microbiol. Biotechnol. 20, 96-104 (2011).
133. Marra A, Asundi J, Bartilson M et al. Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis. Infect. Immun. 70, 1422-1433 (2002).
134. Sebert ME, Palmer LM, Rosenberg M, Weiser JN. Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect. Immun. 70, 4059-4067 (2002).
135. Throup JP, Koretke KK, Bryant AP et al. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol. Microbiol. 35, 566-576 (2000).
136. Ibrahim YM, Kerr AR, McCluskey J, Mitchell TJ. Control of virulence by the two-component system CiaR/H is mediated via HtrA, a major virulence factor of Streptococcus pneumoniae. J. Bacteriol. 186, 5258-5266 (2004).
137. Halfmann A, Kovács M, Hakenbeck R, Brückner R. Identification of the genes directly controlled by the response regulator CiaR in Streptococcus pneumoniae: five out of fifteen promoters drive expression of small noncoding RNAs. Mol. Microbiol. 66, 110-126 (2007).
138. Dias R, Felix D, Canica M, Trombe MC. The highly conserved serine threonine kinase StkP of Streptococcus pneumoniae contributes to penicillin susceptibility independently from genes encoding penicillin-binding proteins. BMC Microbiol. 9, 121 (2009).
139. Maestro B, Novaková L, Hesek D et al. Recognition of peptidoglycan and β-lactam antibiotics by the extracellular domain of the Ser/Thr protein kinase StkP from Streptococcus pneumoniae. FEBS Lett. 585, 357-363 (2011).
140. Giefing C, Jelencsics KE, Gelbmann D, Senn BM, Nagy E. The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro. Microbiology 156, 1697-1707 (2011).
141. Tran TD, Kwon HY, Kim EH et al. Decrease in penicillin susceptibility due to heat shock protein ClpL in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 55, 2714-2728 (2011).
142. Macheboeuf P, Fischer D, Zervosen A et al. Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins. Nat. Chem. Biol. 3, 565-569 (2007). Outlines the consequences of mutations for the interaction with inhibitors - old and new.
143. Miguet L, Zervosen A, Gerards T et al. Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening. J. Med. Chem. 52, 5926-5936 (2009).
144. Oliva M, Dideberg O, Field MJ. Understanding the acylation mechanisms of active-site serine penicillin-recognizing proteins: a molecular dynamics simulation study. Proteins 53, 88-100 (2003).